Table 6.
Total fat mass | Perigonadal pad weight | Subcutaneous pad weight | PGAT:SQAT ratio | Circulating leptin | ||
---|---|---|---|---|---|---|
Pparg | R | nsb | 0.34 | Ns | 0.43 | 0.42 |
P value | ns | 0.043 | Ns | 0.009 | 0.005 | |
Cebpa | R | ns | 0.43 | Ns | 0.38 | ns |
P value | ns | 0.009 | Ns | 0.025 | ns | |
Vdr | R | ns | Ns | Ns | 0.42 | ns |
P value | – | Ns | Ns | 0.010 | ns | |
Lep | R | 0.42 | 0.48 | Ns | ns | 0.46 |
P value | 0.044 | 0.003 | Ns | ns | 0.007 | |
Adip | R | ns | Ns | Ns | ns | ns |
P value | ns | Ns | Ns | ns | ns |
Data are r-unadjusted Pearson correlation coefficients; P value represents the significance of the correlation
ns, non-significant correlation (P > 0.05); bold values indicate statistical significance, P<0.05. Adip, adiponectin; Cebpa, CCAAT/enhancer-binding protein-alpha; Lep, leptin; PGAT, perigonadal adipose tissue; Ppar, peroxisome proliferator-activated receptor gamma; SQAT, subcutaneous adipose tissue; Vdr, vitamin D receptor.